Laserfiche WebLink
TABLE OF CONTENTS <br /> Page <br /> ARTICLE 1. DEFINITIONS AND EXHIBITS.....................................................................3 <br /> Section 1.1. Terms Defined..................................................................................................3 <br /> Section 1.2. Rules of Interpretation......................................................................................6 <br /> Section1.3. Exhibits.............................................................................................................6 <br /> ARTICLE 1I. REPRESENTATIONS .....................................................................................7 <br /> Section 2.1. Representations by Issuer.................................................................................7 <br /> Section 2.2. Representations by Developer..........................................................................7 <br /> Section 2.3. Financing of Series 2017 Bond Proceeds by Issuer..........................................8 <br /> ARTICLE III. PARTICULAR COVENANTS OF THE DEVELOPER.................................9 <br /> Section 3.1. Consent to Assignments to Trustee..................................................................9 <br /> Section 3.2. General Covenants............................................................................................9 <br /> Section 3.3. Continuing Existence and Qualification;Assignment, Sale or Other <br /> Dispositionof Facilities....................................................................................9 <br /> Section 3.4. Developer Duties Under Indenture.................................................................10 <br /> Section 3.5. Assignment, Sale or Other Disposition of Project..........................................10 <br /> Section 3.6. Trustee's Right to Perform Developer's Covenants; Advances......................10 <br /> Section3.7. Indemnity........................................................................................................10 <br /> Section 3.8. Funding of Indenture Funds; Investments......................................................10 <br /> Section 3.9. Completion of Project.....................................................................................11 <br /> Section 3.10. Sale, Substitution, or Lease of the Project......................................................1 l <br /> Section 3.11. Section 118 Nonshareholder Contribution.....................................................11 <br /> Section 3.12. Section 118 Tax Accounting ..........................................................................12 <br /> ARTICLE IV. APPLICATION OF SERIES 2017 BOND PROCEEDS...............................13 <br /> Section 4.1. Use of 2017 Bond Proceeds by Issuer............................................................13 <br /> Section 4.2. Use of TIF Revenues......................................................................................13 <br /> Section 4.3. Estoppel Certificate ........................................................................................13 <br /> ARTICLE V. EVENTS OF DEFAULT................................................................................14 <br /> Section 5.1. Events of Default............................................................................................14 <br /> Section 5.2. Remedies Cumulative.....................................................................................15 <br /> Section 5.3. Delay or Omission Not a Waiver....................................................................15 <br /> Section5.4. Reserved .........................................................................................................15 <br /> Section 5.5. Remedies Subject to Provisions of Law.........................................................15 <br /> Section 5.6. Waiver of Events of Default...........................................................................15 <br /> ARTICLEVI. IMMUNITY ...................................................................................................16 <br /> Section6.1. Immunity.........................................................................................................16 <br /> ARTICLE VII. SUPPLEMENTS AND AMENDMENTS TO THIS FINANCING <br /> AGREEMENT................................................................................................17 <br /> 1\1 1853148.2 <br />